Evidence map›Paper›PMID 37968638›Full record

ArticleGenome medicine2023

The role of admixture in the rare variant contribution to inflammatory bowel disease.

Courtney Astore, Shivam Sharma, Sini Nagpal, NIDDK IBD Genetics Consortium, David J Cutler, John D Rioux, Judy H Cho, Dermot P B McGovern, Steven R Brant, Subra Kugathasan and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Courtney AstoreCenter for Integrative Genomics and School of Biological Sciences, Georgia Institute of Technology, Krone EBB1 Building, 950 Atlantic Drive, Atlanta, GA, 30332, USA.
Shivam SharmaCenter for Integrative Genomics and School of Biological Sciences, Georgia Institute of Technology, Krone EBB1 Building, 950 Atlantic Drive, Atlanta, GA, 30332, USA.
Sini NagpalCenter for Integrative Genomics and School of Biological Sciences, Georgia Institute of Technology, Krone EBB1 Building, 950 Atlantic Drive, Atlanta, GA, 30332, USA.
NIDDK IBD Genetics Consortium
David J CutlerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.
John D RiouxDepartment of Medicine, Université de Montréal and the Montreal Heart Institute Research Center, Montreal, QC, H1Y3N1, Canada.
Judy H ChoCharles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Dermot P B McGovernDepartment of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 08901, USA.
Steven R BrantImmunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Subra KugathasanDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.
I King JordanCenter for Integrative Genomics and School of Biological Sciences, Georgia Institute of Technology, Krone EBB1 Building, 950 Atlantic Drive, Atlanta, GA, 30332, USA.
Greg GibsonCenter for Integrative Genomics and School of Biological Sciences, Georgia Institute of Technology, Krone EBB1 Building, 950 Atlantic Drive, Atlanta, GA, 30332, USA. greg.gibson@biology.gatech.edu.ORCID 0000-0002-5352-5877
Georgia Institute of Technology · USEmory University · USCedars-Sinai Medical Center · USIcahn School of Medicine at Mount Sinai · USMontreal Heart Institute · CARutgers, The State University of New Jersey · US

Funding

Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBDU24DK062429 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ling-shiang Chuang, Ron Do · 2017 to 2026
$13.9M
Yale University Inflammatory Bowel Disease Genetics Research CenterU01DK062422 · NIDDK · YALE UNIVERSITY · PI Ling-shiang Chuang · 2002 to 2026
$10.8M
IBD Gene Mapping by Clinical and Population SubsetsU01DK062431 · NIDDK · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Steven R Brant · 2002 to 2026
$10.7M
Gene discoveries in subjects with Crohn's disease of African descentR01DK087694 · NIDDK · EMORY UNIVERSITY · PI KUGATHASAN, SUBRA · 2011 to 2023
$10.3M
Impact of Genetic Variability on Cellular Pathways and Host-Microbiome InteractioU01DK062423 · NIDDK · SINAI HEALTH SYSTEM · PI MARK S. SILVERBERG · 2002 to 2026
$7.5M
Integrative multi-omic risk assessment at diagnosis and during disease progression in African-Americans with Inflammatory bowel diseaseU01DK134191 · NIDDK · EMORY UNIVERSITY · PI SUBRA KUGATHASAN · 2022 to 2026
$2.8M
Transcriptomics of Pain in Sickle Cell DiseaseR01HL164583 · NHLBI · EMORY UNIVERSITY · PI SHEEHAN, VIVIEN ANDREA · 2022 to 2025
$1.5M
Genomic Analysis of Perianal Fistulizing Crohn's Disease across AncestriesR01DK125936 · NIDDK · EMORY UNIVERSITY · PI KUGATHASAN, SUBRA · 2020 to 2022
$1.2M
New computational, transcriptional, and genome editing approaches to the biology of inflammatory bowel diseaseR01DK119991 · NIDDK · GEORGIA INSTITUTE OF TECHNOLOGY · PI GIBSON, GREGORY C · 2018 to 2021
$692k
NHLBI NIH HHS R01 HL164583NIDDK NIH HHS R01 DK119991NIDDK NIH HHS R01 DK125936NIDDK NIH HHS U01 DK062422NIDDK NIH HHS U01 DK062423NIDDK NIH HHS U01 DK062431NIDDK NIH HHS U24 DK062429
6 · The paper itself

Abstract

backgroundIdentification of rare variants involved in complex, polygenic diseases like Crohn's disease (CD) has accelerated with the introduction of whole exome/genome sequencing association studies. Rare variants can be used in both diagnostic and therapeutic assessments; however, since they are likely to be restricted to specific ancestry groups, their contributions to risk assessment need to be evaluated outside the discovery population. Prior studies implied that the three known rare variants in NOD2 are absent in West African and Asian populations and only contribute in African Americans via admixture.

methodsWhole genome sequencing (WGS) data from 3418 African American individuals, 1774 inflammatory bowel disease (IBD) cases, and 1644 controls were used to assess odds ratios and allele frequencies (AF), as well as haplotype-specific ancestral origins of European-derived CD variants discovered in a large exome-wide association study. Local and global ancestry was performed to assess the contribution of admixture to IBD contrasting European and African American cohorts.

resultsTwenty-five rare variants associated with CD in European discovery cohorts are typically five-fold lower frequency in African Americans. Correspondingly, where comparisons could be made, the rare variants were found to have a predicted four-fold reduced burden for IBD in African Americans, when compared to European individuals. Almost all of the rare CD European variants were found on European haplotypes in the African American cohort, implying that they contribute to disease risk in African Americans primarily due to recent admixture. In addition, proportion of European ancestry correlates the number of rare CD European variants each African American individual carry, as well as their polygenic risk of disease. Similar findings were observed for 23 mutations affecting 10 other common complex diseases for which the rare variants were discovered in European cohorts.

conclusionsEuropean-derived Crohn's disease rare variants are even more rare in African Americans and contribute to disease risk mainly due to admixture, which needs to be accounted for when performing cross-ancestry genetic assessments.

Indexed as

Crohn DiseaseInflammatory Bowel DiseasesBlack or African AmericanGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPolymorphism, Single NucleotideWhiteCrohn’s diseaseGenetic risk assessmentNOD2Trans-ancestryWhole genome sequencing

Identifiers

PMID37968638
PMCPMC10647102
OpenAlexW4388704591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.